Our mission
The PPOL team aims to identify novel druggable entry points
for pediatric solid tumors with a high unmet medical need,
focussing particularly on neuroblastoma and sarcomas.
To this end, we implement innovative in vitro and in vivo model
systems combined with multi-omics read-outs.
We are very greatful to our funders:
